Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

Malaria continues being a high-impact disease regarding public health worldwide; the WHO report for malaria in 2018 estimated that 219 million cases occurred in 2017, mostly caused by the parasite Plasmodium falciparum. The disease cost the lives of more than 400,000 people, mainly in Africa. In spi...

Full description

Autores:

Lambraño, Jennifer
Curtidor, Hernando
Avendaño, Catalina
Díaz Arévalo, Diana
Roa, Leonardo
Vanegas, Magnolia
Patarroyo, Manuel Elkin
Patarroyo, Manuel A.

Tipo de recurso:

Article of journal

Fecha de publicación:

2019

Institución:

Universidad de Ciencias Aplicadas y Ambientales U.D.C.A

Repositorio:

Repositorio Institucional UDCA

Idioma:

eng

OAI Identifier:

oai:repository.udca.edu.co:11158/3245

Acceso en línea:

https://www.hindawi.com/journals/jir/2019/3832513

Palabra clave:

Plasmodium falciparum
Malaria
Malaria Falciparum
Eritrocitos
Adjuvant
Immune protection inducing protein structure vaccine
Malaria vaccine
Plasmodium falciparum protein
Protozoal protein
Unclassified drug

Rights

openAccess

License

Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales